My Jonasson

Uppsala University

H指数:15

被引数:927

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-dose testosterone administration and oestrogen synthase availability in the female brain: A pilot study

低剂量睾酮给药和雌激素合成酶在女性大脑中的可用性：一项初步研究

Journal of Neuroendocrinology

IF4.1

2026-03-020

OAAI

A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using 11C-PE2I PET

基于数据驱动的SSM/PCA分析方法，用于利用11C-PE2I PET对帕金森综合征进行鉴别诊断

NeuroImage-Clinical

IF3.6

2026-02-010

OAAI

Non-invasive modelling and parametric methods for quantification of MAO-B activity using [ ¹¹ C]L-deprenyl-D2 PET

使用 [量化mao-b活性的非侵入性建模和参数方法 <sup>11</sup> C]L-deprenyl-D2宠物

journal of cerebral blood flow and metabolism

IF0

2026-01-160

PRE

Impact of image reconstruction on cerebral blood flow measured with 15O-water positron emission tomography

图像重建对用¹⁵O-水正电子发射断层扫描测量的脑血流的影响

EJNMMI Physics

IF3.2

2025-06-060

OAAI

Quantitation of mitral regurgitation using positron emission tomography

EJNMMI RESEARCH

IF3

2024-09-180

OAAI

Acute nicotine exposure blocks aromatase in the limbic brain of healthy women: A [11C]cetrozole PET study

COMPREHENSIVE PSYCHIATRY

IF4.2

2023-05-013

Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

IF4.5

2023-03-133

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy

艾司西酞普兰和认知行为疗法联合治疗后，社交焦虑障碍中的5-羟色胺和多巴胺转运蛋白可用性

TRANSLATIONAL PSYCHIATRY

IF6.2

2022-10-074

OAAI

Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial

TRANSLATIONAL PSYCHIATRY

IF6.2

2021-11-0327

OAAI

Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study

MOLECULAR PSYCHIATRY

IF10.1

2019-12-1039

OAAI

Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET

NEUROIMAGE-CLINICAL

IF3.6

2019-01-013

OAAI

Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits

TRANSLATIONAL PSYCHIATRY

IF6.2

2018-08-2815

OAAI

Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease

ALZHEIMERS & DEMENTIA

IF11.1

2017-12-1815

OAAI

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia

MOLECULAR PSYCHIATRY

IF10.1

2017-05-1675

OAAI

Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-11-0118

PREAI

Alterations in the serotonergic and substance P systems in posttraumatic stress disorder

MOLECULAR PSYCHIATRY

IF10.1

2016-09-193

OAAI

Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2016-03-21108

OAAI

Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2016-01-2149

OAAI

Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study

MOLECULAR PSYCHIATRY

IF10.1

2015-12-0122

OAAI

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171

TRANSLATIONAL PSYCHIATRY

IF6.2

2015-07-0718

OAAI

My Jonasson

个人简介

教育背景

工作经历

荣誉奖项

研究方向